|
|
||||||||||
|
J Am Coll Cardiol, 1994; 23:384-389 © 1994 by the American College of Cardiology Foundation |
Department of Radiology, University of Washington School of Medicine, Seattle.
OBJECTIVES. The purpose of this study was to determine the safety of adenosine infusion at 140 micrograms/kg per min in conjunction with radionuclide imaging in 9,256 consecutive patients. BACKGROUND. Adenosine produces maximal myocardial hyperemia directly with a rapid onset of action. In addition, when used in conjunction with radionuclide perfusion imaging, it has proven efficacy for the diagnosis of coronary artery disease in patients unable to exercise. Because the ultrashort half-life (< 10s) allows dose titration and rapid reversal of side effects, it may be safer than other available pharmacologic agents. METHODS. Patients were prospectively entered at 21 clinical sites. Information on safety and adverse events during and immediately after adenosine infusion was maintained in the Adenoscan Multicenter Trial Registry. RESULTS. The infusion protocol was completed in 80% of patients, required dose reduction in 13% and was terminated early in 7%. Interpretable imaging studies were obtained in 98.7% of patients, and 0.8% of patients received aminophylline. Minor and well tolerated side effects were reported in 81.1% of patients. There were no deaths, one myocardial infarction, seven episodes of severe bronchospasm and one episode of pulmonary edema. Transient atrioventricular (AV) node block occurred in 706 patients (first-degree in 256, second-degree in 378 and third-degree in 72) and resolved spontaneously in most patients (n = 508) without alteration in the adenosine infusion. There were no sustained episodes of AV block. Patients > 70 years of age had an increased risk of developing AV block (age < 70, 7.05% vs. > or = 70, 9.44%, p = 0.001, relative risk 1.37). CONCLUSIONS. Adenosine infusion is safe. Vasodilator and negative dromotropic side effects are generally well tolerated. Serious side effects are relatively rare, and they reverse with termination of adenosine infusion. Interpretable radionuclide studies were obtained in 98.7% of patients and aminophylline reversal was seldom required.
This article has been cited by other articles:
![]() |
O. Gaemperli, T. Schepis, I. Valenta, P. Koepfli, L. Husmann, H. Scheffel, S. Leschka, F. R. Eberli, T. F. Luscher, H. Alkadhi, et al. Functionally Relevant Coronary Artery Disease: Comparison of 64-Section CT Angiography with Myocardial Perfusion SPECT Radiology, August 1, 2008; 248(2): 414 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Cerqueira, P. Nguyen, P. Staehr, S. R. Underwood, A. E. Iskandrian, and on behalf of the ADVANCE-MPI Trial Investigators Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging: Integrated ADVANCE-MPI Trial Results J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 307 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schwitter, C. M. Wacker, A. C. van Rossum, M. Lombardi, N. Al-Saadi, H. Ahlstrom, T. Dill, H. B.W. Larsson, S. D. Flamm, M. Marquardt, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Eur. Heart J., February 2, 2008; 29(4): 480 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schepis, O. Gaemperli, V. Treyer, I. Valenta, C. Burger, P. Koepfli, M. Namdar, I. Adachi, H. Alkadhi, and P. A. Kaufmann Absolute Quantification of Myocardial Blood Flow with 13N-Ammonia and 3-Dimensional PET J. Nucl. Med., November 1, 2007; 48(11): 1783 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P Greenwood, J F Younger, J P Ridgway, M U Sivananthan, S G Ball, and S Plein Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction Heart, November 1, 2007; 93(11): 1363 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan and A. S. Habib Adenosine as a Non-Opioid Analgesic in the Perioperative Setting Anesth. Analg., August 1, 2007; 105(2): 487 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gaemperli, T. Schepis, I. Valenta, L. Husmann, H. Scheffel, V. Duerst, F. R. Eberli, T. F. Luscher, H. Alkadhi, and P. A. Kaufmann Cardiac Image Fusion from Stand-Alone SPECT and CT: Clinical Experience J. Nucl. Med., May 1, 2007; 48(5): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Attili and P. N. Cascade CT and MRI of Coronary Artery Disease:Evidence-Based Review. Am. J. Roentgenol., December 1, 2006; 187(6 Suppl): S483 - S499. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chuaychoo, M.-G. Lee, M. Kollarik, R. Pullmann Jr, and B. J. Undem Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs J. Physiol., September 1, 2006; 575(2): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Klem, J. F. Heitner, D. J. Shah, M. H. Sketch Jr, V. Behar, J. Weinsaft, P. Cawley, M. Parker, M. Elliott, R. M. Judd, et al. Improved Detection of Coronary Artery Disease by Stress Perfusion Cardiovascular Magnetic Resonance With the Use of Delayed Enhancement Infarction Imaging J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1630 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hendel, T. M. Bateman, M. D. Cerqueira, A. E. Iskandrian, J. A. Leppo, B. Blackburn, and J. J. Mahmarian Initial Clinical Experience With Regadenoson, a Novel Selective A2A Agonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2069 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Miller Impact of Selective Adenosine A2A Receptor Agonists on Cardiac Imaging: Feeling the Lightning, Waiting on the Thunder J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2076 - 2078. [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann, M. Namdar, F. Matthew, M. Roffi, S. V. Aschkenasy, B. van der Loo, G. Sutsch, T. F. Luscher, and R. Jenni Novel Doppler Assessment of Intracoronary Volumetric Flow Reserve: Validation Against PET in Patients With or Without Flow-Dependent Vasodilation J. Nucl. Med., August 1, 2005; 46(8): 1272 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Mishra, S. Dorbala, G. Logsetty, A. Hassan, T. Heinonen, H. R. Schelbert, M. F. Di Carli, and RAMPART Investigators Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: Implications for myocardial perfusion imaging J. Am. Coll. Cardiol., February 15, 2005; 45(4): 553 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koepfli, C. A. Wyss, M. Namdar, M. Klainguti, G. K. von Schulthess, T. F. Luscher, and P. A. Kaufmann {beta}-Adrenergic Blockade and Myocardial Perfusion in Coronary Artery Disease: Differential Effects in Stenotic Versus Remote Myocardial Segments J. Nucl. Med., October 1, 2004; 45(10): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann, O. Rimoldi, T. Gnecchi-Ruscone, R. S. Bonser, T. F. Luscher, and P. G. Camici Systemic Inhibition of Nitric Oxide Synthase Unmasks Neural Constraint of Maximal Myocardial Blood Flow in Humans Circulation, September 14, 2004; 110(11): 1431 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kubo, E. Tadamura, H. Toyoda, M. Mamede, M. Yamamuro, Y. Magata, T. Mukai, H. Kitano, N. Tamaki, and J. Konishi Effect of Caffeine Intake on Myocardial Hyperemic Flow Induced by Adenosine Triphosphate and Dipyridamole J. Nucl. Med., May 1, 2004; 45(5): 730 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fleischmann, P. Koepfli, M. Namdar, C. A. Wyss, R. Jenni, and P. A. Kaufmann Gated 99mTc-Tetrofosmin SPECT for Discriminating Infarct from Artifact in Fixed Myocardial Perfusion Defects J. Nucl. Med., May 1, 2004; 45(5): 754 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koepfli, T. F. Hany, C. A. Wyss, M. Namdar, C. Burger, A. V. Konstantinidis, T. Berthold, G. K. von Schulthess, and P. A. Kaufmann CT Attenuation Correction for Myocardial Perfusion Quantification Using a PET/CT Hybrid Scanner J. Nucl. Med., April 1, 2004; 45(4): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Udelson, G. V. Heller, F. J.Th. Wackers, A. Chai, D. Hinchman, P. S. Coleman, V. Dilsizian, M. DiCarli, R. Hachamovitch, J. R. Johnson, et al. Randomized, Controlled Dose-Ranging Study of the Selective Adenosine A2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion Imaging Circulation, February 3, 2004; 109(4): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Anagnostopoulos, M Harbinson, A Kelion, K Kundley, C Y Loong, A Notghi, E Reyes, W Tindale, and S R Underwood Procedure guidelines for radionuclide myocardial perfusion imaging Heart, January 1, 2004; 90(90001): i1 - 10. [Full Text] [PDF] |
||||
![]() |
C. A. Wyss, P. Koepfli, G. Fretz, M. Seebauer, C. Schirlo, and P. A. Kaufmann Influence of Altitude Exposure on Coronary Flow Reserve Circulation, September 9, 2003; 108(10): 1202 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Gu, T. Ruan, J.-L. Hong, N. Burki, and L.-Y. Lee Selected Contribution: Hypersensitivity of pulmonary C fibers induced by adenosine in anesthetized rats J Appl Physiol, September 1, 2003; 95(3): 1315 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wyss, P. Koepfli, K. Mikolajczyk, C. Burger, G. K. von Schulthess, and P. A. Kaufmann Bicycle Exercise Stress in PET for Assessment of Coronary Flow Reserve: Repeatability and Comparison with Adenosine Stress J. Nucl. Med., February 1, 2003; 44(2): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elhendy, J. J. Bax, and D. Poldermans Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Riou, M. Ruiz, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, G. A. Beller, and D. K. Glover Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A2A-receptor-mediated coronary vasodilation J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1687 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Meyers, L. Topham, J. Ballow, D. Totah, and R. Wilke Adverse Reactions to Dipyridamole in Patients Undergoing Stress/Rest Cardiac Perfusion Testing J. Nucl. Med. Technol., March 1, 2002; 30(1): 21 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Polad and L M Wilson Myocardial infarction during adenosine stress test Heart, February 1, 2002; 87 (2): e2 - e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Giri, L. J. Shaw, D. R. Murthy, M. I. Travin, D. D. Miller, R. Hachamovitch, S. Borges-Neto, D. S. Berman, D. D. Waters, and G. V. Heller Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease Circulation, January 1, 2002; 105(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, L. M. Riou, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and ATL146e Administered by Either Intravenous Infusion or Bolus Injection Circulation, September 4, 2001; 104(10): 1181 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wei, P. Kuukasjarvi, J. Laurikka, E.-L. Honkonen, S. Kaukinen, S. Laine, and M. Tarkka Cardioprotective Effect of Adenosine Pretreatment in Coronary Artery Bypass Grafting Chest, September 1, 2001; 120(3): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men J. Am. Coll. Cardiol., January 1, 2001; 37(1): 130 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Rodgers, J. Z. Ayanian, G. Balady, J. W. Beasley, K. A. Brown, E. V. Gervino, S. Paridon, M. Quinones, R. C. Schlant, W. L. Winters Jr, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing : A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence Circulation, October 3, 2000; 102(14): 1726 - 1738. [Full Text] [PDF] |
||||
![]() |
G. P. Rodgers, J. Z. Ayanian, G. Balady, J. W. Beasley, K. A. Brown, E. V. Gervino, S. Paridon, M. Quinones, R. C. Schlant, W. L. Winters Jr, et al. American College of Cardiology/American Heart Association clinical competence statement on stress testing: A report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1441 - 1453. [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K. P. Schafers, T. F. Luscher, and P. G. Camici Coronary Heart Disease in Smokers : Vitamin C Restores Coronary Microcirculatory Function Circulation, September 12, 2000; 102(11): 1233 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Belhomme, J. Peynet, E. Florens, O. Tibourtine, M. Kitakaze, and P. Menasche Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann. Thorac. Surg., August 1, 2000; 70(2): 590 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist Circulation, July 25, 2000; 102(4): 438 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann, T. Gnecchi-Ruscone, K. P. Schafers, T. F. Luscher, and P. G. Camici Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia J. Am. Coll. Cardiol., July 1, 2000; 36(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Beller and B. L. Zaret Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease Circulation, March 28, 2000; 101(12): 1465 - 1478. [Full Text] [PDF] |
||||
![]() |
A. Elhendy, R. T. van Domburg, J. J. Bax, R. Valkema, A. E. M. Reijs, E. P. Krenning, and J. R. T. C. Roelandt Safety, Hemodynamic Profile, and Feasibility of Dobutamine Stress Technetium Myocardial Perfusion Single-Photon Emission CT Imaging for Evaluation of Coronary Artery Disease in the Elderly Chest, March 1, 2000; 117(3): 649 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeremias, S. D. Filardo, R. J. Whitbourn, R. S. Kernoff, A. C. Yeung, P. J. Fitzgerald, and P. G. Yock Effects of Intravenous and Intracoronary Adenosine 5'-Triphosphate as Compared With Adenosine on Coronary Flow and Pressure Dynamics Circulation, January 25, 2000; 101(3): 318 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Mahaffey, J. A. Puma, N. A. Barbagelata, M. F. DiCarli, M. A. Leesar, K. F. Browne, P. R. Eisenberg, R. Bolli, A. C. Casas, V. Molina-Viamonte, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1711 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Duvernoy, C. Meyer, V. Seifert-Klauss, F. Dayanikli, I. Matsunari, J. Rattenhuber, C. Hoss, H. Graeff, and M. Schwaiger Gender differences in myocardial blood flow dynamics: Lipid profile and hemodynamic effects J. Am. Coll. Cardiol., February 1, 1999; 33(2): 463 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés Selection of the optimal stress test for the diagnosis of coronary artery disease Heart, October 1, 1998; 80(4): 370 - 376. [Abstract] [Full Text] |
||||
![]() |
D. K. Glover, M. Ruiz, J. Y. Yang, B. A. Koplan, T. R. Allen, W. H. Smith, D. D. Watson, R. J. Barrett, and G. A. Beller Pharmacological Stress Thallium Scintigraphy With 2-Cyclohexylmethylidenehydrazinoadenosine (WRC-0470): A Novel, Short-Acting Adenosine A2A Receptor Agonist Circulation, October 1, 1996; 94(7): 1726 - 1732. [Abstract] [Full Text] |
||||
![]() |
R. F. Redberg, Y. Sobol, T. M. Chou, M. Malloy, S. Kumar, E. Botvinick, and J. Kane Adenosine-Induced Coronary Vasodilatation During Transesophageal Doppler Echocardiography : Rapid and Safe Measurement of Coronary Flow Reserve Ratio Can Predict Significant Left Anterior Descending Coronary Stenosis Circulation, July 15, 1995; 92(2): 190 - 196. [Abstract] [Full Text] |
||||
![]() |
M. P. S. Randhawa Jr., R. D. Lasley, and R. M. Mentzer Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 63 - 74. [Abstract] [Full Text] |
||||
![]() |
ADENOSINE FOR CARDIAC STRESS TESTING Journal Watch (General), March 1, 1994; 1994(301): 4 - 4. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |